ENTITY
Bristol Myers Squibb Co

Bristol Myers Squibb Co (BMY US)

229
Analysis
Health CareUnited States
Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.
more
Exchange Announcement19 Nov 2025 05:41
Exchange Announcement11 Nov 2025 05:06
Exchange Announcement08 Nov 2025 05:11
Exchange Announcement03 Nov 2025 19:09
Exchange Announcement03 Nov 2025 19:02
x